Plasma and cerebrospinal fluid pharmacokinetics of the Akt inhibitor, perifosine, in a non-human primate model

DE Cole, CM Lester-McCully, BC Widemann… - Cancer chemotherapy …, 2015 - Springer
Purpose Central nervous system tumors are histologically and biologically heterogeneous.
Standard treatment for malignant tumors includes surgery, radiation and chemotherapy, yet …
被引用次数：13 相关文章

Plasma and cerebrospinal fluid pharmacokinetics of the Akt inhibitor, perifosine, in a non-human primate model.

DE Cole, CM Lester-McCully… - Cancer …, 2015 - europepmc.org
Purpose Central nervous system tumors are histologically and biologically heterogeneous.
Standard treatment for malignant tumors includes surgery, radiation and chemotherapy, yet …

Plasma and cerebrospinal fluid pharmacokinetics of the Akt inhibitor, perifosine, in a non-human primate model

DE Cole, CM Lester-mccully… - Cancer …, 2015 - search.proquest.com
Central nervous system tumors are histologically and biologically heterogeneous. Standard
treatment for malignant tumors includes surgery, radiation and chemotherapy, yet surgical …
[HTML] nih.gov

[HTML][HTML] Plasma and cerebrospinal fluid pharmacokinetics of the Akt inhibitor, perifosine, in a non‑human primate model

DE Cole, CM Lester-McCully… - Cancer …, 2015 - ncbi.nlm.nih.gov
Purpose Central nervous system tumors are histologically and biologically heterogeneous.
Standard treatment for malignant tumors includes surgery, radiation and chemotherapy, yet …

Plasma and cerebrospinal fluid pharmacokinetics of the Akt inhibitor, perifosine, in a non-human primate model

DE Cole, CM Lester-McCully… - Cancer …, 2015 - pure.johnshopkins.edu
Purpose: Central nervous system tumors are histologically and biologically heterogeneous.
Standard treatment for malignant tumors includes surgery, radiation and chemotherapy, yet …

Plasma and cerebrospinal fluid pharmacokinetics of the Akt inhibitor, perifosine, in a non-human primate model

DE Cole, CM Lester-McCully, BC Widemann… - Cancer Chemotherapy …, 2015 - infona.pl
Purpose Central nervous system tumors are histologically and biologically heterogeneous.
Standard treatment for malignant tumors includes surgery, radiation and chemotherapy, yet …

Plasma and cerebrospinal fluid pharmacokinetics of the Akt inhibitor, perifosine, in a non-human primate model

DE Cole, CM Lester-McCully… - Cancer …, 2015 - pubmed.ncbi.nlm.nih.gov
Purpose Central nervous system tumors are histologically and biologically heterogeneous.
Standard treatment for malignant tumors includes surgery, radiation and chemotherapy, yet …

Plasma and cerebrospinal fluid pharmacokinetics of the Akt inhibitor, perifosine, in a non-human primate model.

D Cole, C Lester-McCully… - Cancer …, 2015 - search.ebscohost.com
Purpose: Central nervous system tumors are histologically and biologically heterogeneous.
Standard treatment for malignant tumors includes surgery, radiation and chemotherapy, yet …

Plasma and cerebrospinal fluid pharmacokinetics of the Akt inhibitor, perifosine, in a non-human primate model

DE Cole, CM Lester-McCully, BC Widemann… - Cancer Chemotherapy …, 2015 - infona.pl
Purpose Central nervous system tumors are histologically and biologically heterogeneous.
Standard treatment for malignant tumors includes surgery, radiation and chemotherapy, yet …

Plasma and cerebrospinal fluid pharmacokinetics of the Akt inhibitor, perifosine, in a non-human primate model.

DE Cole, CM Lester-McCully… - Cancer …, 2015 - europepmc.org
Purpose Central nervous system tumors are histologically and biologically heterogeneous.
Standard treatment for malignant tumors includes surgery, radiation and chemotherapy, yet …